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ABSTRACT
Background: This was a retrospective study that evalu-
ated the surgical outcomes of laparoscopic surgery (LS)
for rectal cancer, in comparison with a case control series
of open surgery (OS), during an 8-year period.
Methodology: Between October 1998 and December
2006, 203 patients with rectal malignancies underwent
colectomy; 146 of them had colectomy with the traditional
technique (OS), while 57 underwent resection of rectal
cancer laparoscopically (LS). The LS group was compared
with 60 patients from the OS group (selected from the 146
OS group patients), matched by size, sex, age, anatomical
location of the tumor, type, extent of resection, and patho-
logical stage. Data were obtained from patients’ medical
records. Statistical analysis was performed with the t test
and chi-square test. All data are expressed as mean 
standard error of the mean (SEM).
Results: Mean age of the LS group was 63.712 years
versus 6912 years in the OS group. There were more
men than women in both the laparoscopic (33 males, 24
females) and OS groups (35 men, 25 women). The mean
follow-up period was 38 months and 78 months for LS and
OS groups, respectively. The procedure included low an-
terior resection (43 in LS and 45 in OS), and 13 patients in
both groups underwent abdominoperineal resection and
3 transanal resections (2 in OS and 1 in LS). Mean tumor
size was 4.22.12cm in the LS versus 5.22.02cm in the
OS group. Conversion to an open procedure occurred in
4 patients (6.7%), all in the first 20 cases. Postoperative
complications developed in 28 patients (11.7%), 13 in the
LS group and 15 in the OS group. Median operative time
was longer, but median blood loss was significantly lower
in the LS group. The length of hospital stay was signifi-
cantly shorter for the LS group.
Conclusion: Laparoscopic surgery is feasible and safe for
patients with rectal cancer and provides benefits during
the postoperative period without increased morbidity or
mortality.
Key Words: Laparoscopic surgery, Rectal carcinoma,
Laparoscopic anterior resection, Leakage, Ileostomy, Sur-
gical outcome.
INTRODUCTION
Laparoscopic resection for rectal cancer has been reported
to achieve acceptable short- and mid-term outcomes and
long-term safety when performed by skilled laparoscopic
surgeons.1–3 Recently, some retrospective comparative
studies have demonstrated several advantages in patients
with rectal malignancies who underwent laparoscopic
surgery compared with patients who underwent surgery
with the traditional technique, including intraoperative
blood loss, decreased postoperative pain, shorter hospital
stay, and favorable effects on immunological status.2–5 In
addition, 2 multicenter trials, the CLASSIC6 and the COLOR,7
demonstrated longer operative time for patients who under-
went laparoscopic surgery, a shorter hospital stay, a shorter
postoperative ileus, less use of postoperative analgesics,
lower postoperative pain scores, and faster return to nor-
mal activities.8–10 However, several studies have reported
the theoretical advantages of LS, such as magnification
and superior exposure allowing better identification of
very critical structures.11,12
Some other reports published recently have examined the
feasibility of laparoscopy for rectal cancer.12,13 In the con-
text of a minimally invasive technique, the omission of a
protective ileostomy has definitive advantages regarding
the overall cosmetic result11
Low recurrence and improvement of postoperative results
after total mesorectal excision (TME) support the value of
removing the fat tissue around the anterolateral rectal
border, known as the mesorectum.14
Symptomatic anastomotic leakage is the most important
complication after surgical operations for rectal carcino-
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SCIENTIFIC PAPERmas. Leakage after low anterior resection can result in
significant morbidity and mortality and may be associated
with a higher local recurrence rate.15,16
The increase in sphincter-saving procedures may contrib-
ute to an increased incidence of anastomotic failure. In
addition, TME potentially compromises the blood supply
to the remaining rectum and thus may compromise anas-
tomotic healing.17–19 Removal of the mesorectum leaves a
large space in the pelvis area in which a hematoma may
accumulate, leading to pelvic sepsis. To avoid all these
difficult situations, it is crucial to take all necessary mea-
sures.18,19
The goal of this study was to compare operative safety,
complications, and oncological outcomes after laparo-
scopic resection in patients with rectal cancer in compar-
ison with a case control series of open surgery.
MATERIALS AND METHODS
Between October 1998 and December 2006, 203 patients
with rectal malignancies underwent colectomy; 146 had
colectomy with the traditional technique (OS), while 57
underwent resection of rectal cancer laparoscopically
(LS). The LS group was compared with 60 patients in the
OS group (selected from the 146 OS patients). Laparo-
scopic surgery was performed by a single surgeon, while
open resection was performed by 3 surgeons, all with
experience in colonic malignancy operations.
All patients, before surgery, were evaluated by clinical
examinations, including colonoscopy, chest radiograph,
barium enema, and CT-abdominal scan.
Excluded from this study were patients with ASA IV, with
T4 tumors, and severe obesity (BMI30 kg/m
2), with
synchronous metastasis, metachronous cancer, familiar
adenomatous polyposis (FAP), histology other than ade-
nocarcinoma, and those who did not consent to laparo-
scopic surgery. Finally, patients with preexisting median
laparotomies were also excluded, because these patients
would not even have had the minimal advantage of a
better cosmetic situation.
The LS group was compared with the OS group of patients
matched for sex, age, location of tumor, surgical proce-
dure, extent of resection, and pathologic stage. The loca-
tion of the tumors was defined according to the distance
from the anal verge, as determined by colonoscopy: lower
rectum (0 cm to 7 cm), middle (7 cm, range, 1 cm to 11
cm), and upper rectum (11 cm, range, 1 cm to 17 cm).
Bowel preparation was performed the day before surgery
by intestinal washout with an iso-osmotic solution (4 li-
ters). The evening before and the morning of the opera-
tion, patients were given an enema. As antibiotic prophy-
laxis, all patients received a single dose of third-
generation cephalosporin (2 g iv) and 500 mg of
metronidazole during induction in anesthesia. A second
dose of metronidazole was given intraoperatively if the
surgical procedure lasted more than 4 hours. All patients
underwent general anesthesia plus epidural anesthesia for
the laparoscopic group patients. All patients received low
molecular-weight heparin plus Daflon 500 mg as a stan-
dard prophylaxis for deep venous thrombosis. Nasogastric
tube was placed intraoperatively and withdrawn immedi-
ately after the end of the surgical procedure.
Neoadjuvant chemoradiotherapy has been standardized at
our institution since 2000 for T3 and T4 lesions. However,
neoadjuvant therapy was used for T2N lesions located at
the lower rectum to achieve a sphincter-saving procedure.
Indeed, 5 patients (1 with B1 and 4 with B2 lesions in
proximity to the dentate line) underwent neoadjuvant
therapy. Adjuvant chemoradiotherapy was routinely per-
formed for stages B2, C1, C2, and D (Duke’s Classifica-
tion), and for patients 75 years of age.
The dose of radiotherapy given pre- or postoperatively
was 50 Gy divided into 20 fractions to 25 fractions for 4
weeks to 5 weeks. For adjuvant chemotherapy, tegafur-
levamisole or 5-fluorouracil – levamisole or Xeloda
was administered to patients with stage B2, C, and D.
We analyzed the oncological results of patients who un-
derwent surgical rectal resection between October 1998
and December 2006. Criteria for determining recurrence
include increase in carcinoembryonic antigen (CEA) level,
histological confirmation, palpable disease, or clear evi-
dence after radiological studies. Peritoneal seeding, local
or regional recurrence, distal lymph node metastasis, and
blood bone metastasis were considered as sites of recur-
rence. Local recurrence was defined as recurrence in areas
continuous to the primary resection or at the site of anas-
tomoses.
Laparoscopic Surgical Technique
All laparoscopic operations were performed by a single
surgeon (ECT) with experience and skill in open and
laparoscopic colorectal surgery. Pneumoperitoneum was
induced by insufflations of CO2 and was maintained be-
tween 9 mm Hg and 12 mm Hg during the entire surgical
procedure. Laparoscopic operations were performed ac-
cording to the technique described by Milsom and Bohm.9
Briefly, a 4-port technique was used in most cases for both
JSLS (2009)13:564–573 565low anterior resection and abdominoperineal resection.
The lymph node resection was started around the origin
of the inferior mesenteric artery, which was divided by
clips at the level of 1cm from its origin in all cases. The
splenic flexure was fully mobilized. The rectum was then
mobilized with an attempt to keep the mesorectal fascia
intact. Before the division of the rectum, rectal washout
was conducted using 120 mL of 5% povidone-iodine so-
lution. The rectum then was divided (for low anterior
resection procedures) by using laparoscopic linear sta-
plers introduced from the left iliac fossa trocar, and the
proximal end of the bowel was delivered through a small
incision of the suprapubic trocar extended to approxi-
mately 4 cm to 6 cm, protected by a plastic cover bag. The
bowel was resected extracorporeally, after an anvil was
placed into the proximal colon, and an anastomosis was
performed intracorporeally by means of the double-sta-
pling technique. All patients underwent total mesorectal
excision (TME). In patients with cancer at the lower rec-
tum, TME was performed, and transverse coloplasty was
fashioned extracorporeally, before the anastomosis was
done, for a neorectal creation. In our department during
the last 7 years, we have preferred the transverse colo-
plasty pouch to the J-pouch.
A diverting (protective) ileostomy was fashioned selec-
tively according to intraoperative events, such as anasto-
moses close to the anal verge, positive air leak test, in-
complete doughnuts, or extreme difficulty with pelvic
dissection. For the abdominoperineal resection, the sig-
moid colon was divided, and the total mesorectal excision
was completed intracorporeally. The perineal dissection
and the end colostomy were constructed in the usual
manner.
Statistical Analysis
Continuous and categorical variables were analyzed using
the Student t test and Fischer’s exact test, respectively.
A P value 0.05 was considered to indicate a statistically
significant difference. Overall and disease-free survival
rates were calculated by the Kaplan-Meier method, Log
Rank test, and Cox Regression proportional hazards.
RESULTS
Laparoscopic mobilization of the colon and rectum was
performed in all patients. In 4 patients, 3 with consider-
able obesity and 1 with severe inflammation of the colon,
the set time limit of 60 minutes was exceeded, and the
patients were primarily converted to a midline laparot-
omy. All 4 patients in which the laparoscopic technique
was not successful had BMI28 kg/m
2. Demographic
characteristics of the patients are summarized in Table 1.
There is a significant difference between the 2 groups
regarding age and sex.
Surgical data are summarized in Table 2. In both groups,
2 patients underwent anterior resection of the rectum with
end-to-end anastomosis of the colon, 1cm to 2cm from the
anal verge. In these patients, a protective ileostomy was
fashioned.
Three patients, one in the LS group and 2 in the OS
group, underwent intersphincteric resection and
coloanal anastomoses (ISR-CAA), and a J-pouch was
fashioned (Table 2).
Seven patients in the LS group, and 10 patients in the OS
group underwent a covering ileostomy. Symptomatic
Table 1.
Demographic Characteristics
Open Laparoscopic P Value
Number of Patients
* 60 57 NS
Age (Year range)
† 68.91  12.555 63.77  12.714 0.032
Sex (Male/Female)
* 35/25 33/24 0.022
BMI (kg/m
2 range)
† 25 (21–30.3) 23 (20–27.7) NS
Follow-up (months) 78 83 NS
*Fisher exact test.
†Data expressed as Mean  SD; Student’s t-test.
‡NSnot significant.
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the OS group and 2 in the LS group, which is comparable
to other reports.13,18 All those patients subsequently un-
derwent closure of the ileostomy (Table 2).
The following details of the surgical procedure were re-
corded for all patients: duration of operation, operative
blood loss, amount of homologous blood transfused, and
number of lymph nodes collected in cancer patients.
Transfusion of blood products in the perioperative period
was based on hemoglobin level (8 g/L), or on an indi-
vidual basis according to the clinical condition.
Intraoperative results and postoperative complications are
shown in Tables 3 and 4. Operative time was longer, and
blood loss was significantly lower in the LS group. Post-
operative recovery of bowel function was evaluated in
terms of first flatus and bowel movement (Table 3).
No patients were allowed an oral feeding before the first
flatus occurred. Any anastomotic dehiscence with either
clinical or radiologic evidence was accepted. Follow-up
for infectious and noninfectious complications was per-
formed for at least 30 days after hospital discharge with
weekly office visits (Table 4).
The first flatus occurred after 1.8 days in the LS group
compared with 3.0 days in the OS group (P0.0001). The
first bowel movement occurred after 2.9 days in the LS
group and 3.8 days in the OS group (P0.0001). Liquid
and solid intakes were started on the first and third post-
operative days in the LS group (Table 3), which was
Table 2.
Surgical Data
Open Laparoscopic P Value*
Year of Surgery
1998–2000 21 19 NS
2001–2003 22 21 NS
2004–2006 17 20 NS
Rectal Tumor Location
Upper 32 35 NS
Middle 18 18 NS
Lower 10 7 NS
Surgical Procedure
Anterior Res 45 43 NS
Abdominoperineal Res 13 13 NS
ISR-CAA 2 1 NS
Protected Ileostomy 10 7 NS
*Fisher exact test; NS  not significant.
Table 3.
Operative Data and Recovery
Open Median (Range) Laparoscopic Median (Range)
Length of Incision (mm) 190 (170–230) 75 (70–110)
Total Anesthetic Time (min) 135 (90–165) 170 (115–205)
Time to First Bowel Movement (days) 3.8 (3–7) 2.9 (2.0–5.5)
Time to Intake Liquids (days) 4.0 (3.9–7) 2.8 (2.5–5.5)
Time to Intake Solids (days) 4.8 (4.0–8) 3.7 (3.3–6.2)
Time to Discharge (days) 11 (9–17) 8 (7–13)
JSLS (2009)13:564–573 567shorter than in the OS group, third and fourth day, respec-
tively (P0.0001).
Oncological data and histopathological stage are summa-
rized in Tables 5 and 6. Statistically significant differences
were observed between the groups regarding tumor size
and pathological stage (Stages C1-C2, D).
A statistically significant correlation was found between
tumor stage, number of lymph nodes infiltrated, and ad-
juvant therapy (Table 7).
Overall survival data are indicated in Table 8. No statis-
tically significant difference was observed between
groups regarding overall survival; although a statistically
significant correlation was found between the 2 groups
regarding survival time (Figure 1), tumor size (Figure 2),
number of lymph nodes infiltrated (Figure 3), preopera-
tive chemo-radiotherapy (Figure 4), and adjuvant ther-
apy (Figure 5) (Table 8).
Hospital stay was approximately 1 week for the LS group,
which was shorter compared with 10 days in the OS
group. No perioperative mortalities occurred in either
group (mean 30 days after surgical procedure). The rate of
bowel obstruction was 3.7% (2/60) in the LS group and
7.3% (5/57) in the OS group, which is significantly in-
creased with respect to the LS group.
Fifteen months after the end of the study, 3 patients (2 in
OS and 1 in LS) developed recurrence. Two patients from
every group died from causes not related to the surgical
procedure.
DISCUSSION
Although laparoscopic-assisted colorectal surgery is well es-
tablished for colon and upper rectal resection, there are
some technical limitations involving resection of mid- and
Table 4.
Intraoperative and Thirty Days Postoperative Complications
Open (15 Total) Laparoscopic (13 Total)
Insignificant Clinical Hemorrhage 1 1
Significant Clinical Hemorrhage 1 1
Bowel Injury 0 1
Bladder Disfunction-Incontinence 1 3
Bladder Injury 0 1
Post-Operative Ileus 2 1
Wound Infection 3 0
Anastomotic Rupture 1 1
Deep Vein Thrombosis 0 0
Pulmonary infection 2 1
Cardiac Insufficiency-Angina Pectoris 1 1
Anastomotic Leak 3 2
Table 5.
Oncological Data*
Open Laparoscopic 95% CI P Value
Tumour Size 5.29 2.02 4.22 2.12 0.27–1.85 0.009
Number of Lymph Nodes
Harvested
15.55 5.48 14.00 7.16 0.8–3.95 NS
Number of Lymph Nodes Infiltrated 1.72 3.01 1.67 3.27 1.14–1.24 NS
Liver Metastases 0.12 0.32 0.02 0.13 0.008–0.19 NS
*Data expressed as mean  SD; Student’s t-test; NS  not significant.
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mid-term outcomes and quality of life in patients who un-
derwent laparoscopic or open proctocolectomy for rectal
cancer.13,14
Conversion of a laparoscopic procedure to open laparot-
omy was performed in 4 patients, all of them during the
first 20 cases. This small percentage of conversions was
achieved because all operations were performed by one
well-trained surgical team.20–21 The importance of one
surgical team was stressed by See et al,21 who reported a
complication rate of approximately 8% when surgeons
performed laparoscopic surgery with a different assistant,
compared with 3% when the surgical procedure was per-
formed by the same assistant.
Conversion itself is not necessarily a negative event, but
the authors think that good selection of patients is reason-
able and justified. We noted serious complications, in
both groups, that required surgical intervention.
Diverting ileostomy is up to the surgeon’s decision at the
moment of surgery. Some surgeons routinely affect a di-
verting ileostomy for laparoscopy low-anterior resection,
in the management of malignancies very close to the
dentate line.15,17–19 In our department, a protective ileos-
tomy was performed in cases with anastomoses lower
than 4cm to 5cm from the anal verge.
Since the introduction of total mesorectal excision (TME)
by Heald,14 TME has become the accepted standard for
rectal cancer surgery. The low recurrence and improved
survival rates in TME series support the crucial value of
removing the fatty tissue around the rectum, known as
mesorectum.14,16 In the multiple regression analysis, the
absence of pelvic drainage after TME and the absence of
a stoma were the 2 factors significantly associated with
high anastomotic dehiscence and an increase in local
recurrence.16–18
After TME surgery, a large presacral space remains in
which a seroma or hematoma may develop, and this
constitutes excellent material for bacteria. Pelvic drain-
age may prevent this process. Several trials, neverthe-
Table 6.
Pathological Stages (Dukes)
Open Laparoscopic P Value*
A1A 9N S
B17B 1 10 NS
B218 B221 NS
C111 C14 0.029
C220 C213 0.008
D3D 0 0.002
*Fisher exact test; NS  not significant.
Table 7.
Correlation Between Survival and Oncological Data*
Mean HR 95% CI P Value
Stage (Dukes) 117 1.21 0.71–2.07 0.47
Stage A 10 0.27 0.03–0.03 0.26
Stage B1 17 0.07 0.06–0.85 0.19
Stage B2 40 0.24 0.49–1.21 0.03
Stage C1 15 0.16 0.22–1.21 0.08
Stage C2 32 0.39 0.84–1.83 0.07
Stage D 3 - - -
Tumor Size 4.74 1.00 0.74–1.35 0.98
Number of Lymph Nodes
Harvested
14.78 0.99 0.90–0.71 0.83
Number of Lymph Nodes Infiltrated 1.62 1.25 1.06–0.74 0.007
Neoadjuvant Therapy 112 1.33 0.11–0.95 0.72
Adjuvant Therapy 115 0.32 0.09–1.12 0.04
*Cox regression.
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all cases.16–18
In our study, patients with very low rectal tumors were
found to be at risk of anastomotic leak, and so, both
groups may benefit from fecal diversion. In many studies,
as in the present one, the decision to construct a stoma
was left to the discretion of the surgeon.18
Previous studies have reported an anastomotic leak rate
from 7.2% to 20% in patients who underwent laparoscopic
low anterior resection.13,18,19 Therefore, some authors rec-
Table 8.
Survival Data
Mean Open/Laparoscopic HR 95% CI P Value
Open vs. Laparoscopic 71.49/82.50 62.87–80.11/75.54–89.45 0.11*
Tumor Size 5.29/4.22 1.49 1.03–2.15 0.031†
Tumor Stage (Dukes) 60/57 1.15 0.95–1.39 0.34†
Stage A 1/9 7.14 0.89–57.18 0.06†
Stage B1 7/10 2.09 0.26–16.81 0.48†
Stage B2 18/22 1.55 0.47–5.04 0.46†
Stage C1 11/4 0.41 0.05–3.39 0.41†
Stage C2 20/12 1.89 0.68–5.29 0.22†
Stage D 3/0 - - -
No of lymph nodes
harvested
15.43/14.13 0.99 0.9–1.10 0.93†
No of lymph odes infiltrated 1.69/1.55 1.67 1.29–2.16 0.0001†
Neoadjuvant Therapy 4/7 15.83 1.04–249.46 0.047†
Adjuvant Therapy 48/29 0.008 0.001–0.78 0.0001†
*Log rank.
†Cox regression.
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Figure 1. Overall survival between the groups.
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Figure 2. Survival function for tumor size.
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procedure.13
In our study, anastomotic leakage occurred in 5 patients
(4.3%), 3 of them in the OS group and 2 in the LS group.
The anastomotic leak rate in our study was similar to that
in other studies between OS and LS groups. A protective
stoma was constructed in 17 patients (13%), 10 in the
group operated on with the traditional technique and 7 in
those patients who underwent laparoscopic resection. In-
creased risk of leak in very low anastomoses is a well-
known concern after open rectal surgery.19–21 During
laparoscopic rectal resection, multiple cartridges (2 or 3
usually) for the linear stapling device are used.22–25 Sta-
plers used multiple times may lead to small defects be-
tween the stapler lines, thus causing anastomotic dehis-
cence. During open surgery, on the other hand, usually
only one cartridge is applied even for the division of a
large volume of rectum.
In 3 patients with tumor 1cm from the dentate line, lapa-
roscopic intersphincteric rectal resection and hand-sewn
colon-anal anastomosis (ISR-CAA) was performed. For
these patients, a J-pouch with covering ileostomy was
fashioned. Having seen the good results achieved with the
transverse coloplasty, we prefer to perform this technique
instead of the J pouch.26–28 However in 3 such patients,
the tumor location was very low, and it was easier to
create a J-pouch.
In a few series, some surgeons expected increased surgi-
cal morbidity as a result of irradiation.29–30 In some re-
ports, it has been shown that preoperative radiotherapy is
a safe treatment with no increase in the surgical compli-
cation rate.29 There was no significant association be-
tween leakage and short-term neoadjuvant radiotherapy,
which has become part of the standard regimen for rectal
cancer treatment in many European countries and Ja-
pan.29–30
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Figure 3. Survival function for number of infiltrated lymph
node.
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Figure 4. Survival function for neoadjuvant chemotherapy.
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Figure 5. Survival function for adjuvant chemotherapy.
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terms of cancer surgery, 3 RCT occurred in patients with
colon and upper rectal cancer, indicating that the outcome
of LS is equal to or better than that of OS.20,21
Analysis of operative variables confirmed that laparo-
scopic surgery (in the treatment of rectal cancer) took
longer, caused less bleeding, and the need for homolo-
gous blood transfusion was reduced, compared with the
these things in the OS group.22,27,28
Only the duration of surgery was longer in the LS group,
and this is related to the increase in postoperative com-
plications.27,28,31
Blood transfusion has been previously identified as the
most important factor in postoperative complications.22 It
is very important to avoid administering homologous
blood to the patient with rectal cancer who underwent
curative surgery, because of the increased risk of postop-
erative complications.23–25 At our institution, blood trans-
fusion was administrated to 7 patients, 5 in the OS and 2
in the LS group (P0.0001).
The LS group had a significantly lower postoperative in-
fection rate than the OS group had. The most relevant
effect in the LS group was the reduction in wound infec-
tions, which is in accordance with that in previous studies.
Minimal wound trauma, shorter incision, and less manip-
ulation in the intestine were factors involved in decreasing
wound infection and postoperative ileus in the LS
group.20,21
One of the advantages of LS for rectal cancer is the mag-
nification of the operative field; thus, the surgeon can
safely mobilize the rectum because of the easy identifica-
tion of the loose connective tissue between the mesorec-
tum and the surrounding tissues, such as the hypogastric
nerve and the pelvic nerve, which is not always easy to
recognize under direct vision during OS. Another advan-
tage of LS is that everyone participating in the surgical
procedure can have the same field of view.
Patients who underwent LS had a faster recovery of bowel
function than patients did who had open surgery.
CONCLUSION
The findings of this study demonstrate that LS for rectal
cancer can be performed safely by an experienced team;
it reduces the rate of postoperative complications, the
need for blood transfusions, infections, and the length of
hospital stay. In an attempt to minimize the risk of clinical
leakage, we recommend construction of a protective il-
eostomy, which seems advisable for patients with a 4-cm
to 5-cm anastomosis from the anal verge. Placement of at
least one drain after TME for rectal cancer is also recom-
mended.
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